Annual Report

Overview

The report describes a transformational 2025, with revenue increasing 50% to £6.0m and significant cost reductions. The company completed the sale of 51% of Creo Medical Europe, generating £24.7m of net cash consideration and retaining a 49% interest. It exited the year with 104 direct employees across the USA, UK, Europe and Asia. Sustainability priorities include net-zero Scope 1 and 2 emissions by 2027, net-zero Scope 3 emissions by 2045, and expanded emissions data capture.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: Ends 31 December 2025
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services